REFERENCES
1. Tang S, Liang C, Yu H, et al. The potential serum sphingolipid biomarkers for distinguishing Wilson disease. Clin Chim Acta. 2024;553:117740.
2. Li S, Lin Y, Chen S, et al. Clinical characteristics and prognosis of early diagnosed Wilson’s disease: a large cohort study. Liver Int. 2024;44:2424-33.
3. Yang RM, Feng T, Cai W, et al. Chinese multidisciplinary expert consensus on orphan/anticopper drugs and other non-drug management of hepatolenticular degeneration. Curr Neuropharmacol. 2025;23:1683-708.
4. Roberts EA, Schilsky ML. Current and emerging issues in Wilson’s disease. N Engl J Med. 2023;389:922-38.
5. Cai H, Cheng X, Wang XP. ATP7B gene therapy of autologous reprogrammed hepatocytes alleviates copper accumulation in a mouse model of Wilson’s disease. Hepatology. 2022;76:1046-57.
6. Brennan PN, Cartlidge P, Manship T, Dillon JF. Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI). Frontline Gastroenterol. 2022;13:332-6.
7. Antczak-Kowalska M, Członkowska A, Eyileten C, et al. Autoantibodies in Wilson disease: impact on clinical course. JIMD Rep. 2022;63:508-17.
8. Jańczyk W, Bierła JB, Trojanowska I, Wierzbicka-Rucińska A, Cukrowska B, Socha P. Prevalence and significance of autoantibody seropositivity in children with Wilson’s disease. Diagnostics. 2023;13:768.
9. Santos BC, Guedes LR, Faria LC, Couto CA. Wilson’s disease presentation resembling autoimmune hepatitis. BMJ Case Rep. 2019;12:e230721.
10. Milkiewicz P, Saksena S, Hubscher SG, Elias E. Wilson’s disease with superimposed autoimmune features: report of two cases and review. J Gastroenterol Hepatol. 2000;15:570-4.
11. Lopes SR, Teixeira M, Sequeira C, Carvalho A, Gamito É, Alves AL. Diagnostic pitfalls in Wilson disease with autoimmune features: a case report. GE Port J Gastroenterol. 2025;Epub ahead of print.
12. Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int. 2003;23:139-42.
13. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406-60. (in Chinese).
14. Medical Association Tuberculosis Branch. [Guidelines for diagnosis and management of drug-induced liver injury caused by anti-tuberculosis drugs (2024 version)]. Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:1069-90.
15. Hadjout T, Lamara Mahammed L, Saad M, et al. Is there an alternative to the indirect immunofluorescence ANA HEp-2 assay for the diagnosis of connective tissue diseases? Front Immunol. 2025;16:1669124.
16. Inherited Metabolic Liver Disease Collaboration Group, Chinese Society of Hepatology, Chinese Medical Association. [Guidelines for the diagnosis and treatment of hepatolenticular degeneration (2022 edition)]. Zhonghua Gan Zang Bing Za Zhi. 2022;30:9-20. (in Chinese).
17. Chowdhury AB, Mehta KJ. Liver biopsy for assessment of chronic liver diseases: a synopsis. Clin Exp Med. 2023;23:273-85.
18. Arase Y, Matsumoto K, Anzai K, et al. Clinicopathological features of autoimmune hepatitis with IgG4-positive plasma cell infiltration. Dig Dis. 2021;39:225-33.
19. Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77:1797-835.
20. Pashnina IA, Krivolapova IM, Fedotkina TV, et al. Antinuclear autoantibodies in health: autoimmunity is not a synonym of autoimmune disease. Antibodies. 2021;10:9.
21. Association for the Study of the Liver. EASL-ERN Clinical Practice Guidelines on Wilson’s disease. J Hepatol. 2025;Epub ahead of print.
22. Dara N, Imanzadeh F, Sayyari AA, Nasri P, Hosseini AH. Simultaneous presentation of Wilson’s disease and autoimmune hepatitis; a case report and review of literature. Hepat Mon. 2015;15:e29043.
23. Rosenblum MD, Remedios KA, Abbas AK. Mechanisms of human autoimmunity. J Clin Invest. 2015;125:2228-33.
24. Shlomchik MJ, Craft JE, Mamula MJ. From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol. 2001;1:147-53.
